| MEDIOLANUM DYNAMIC INTERNATIONAL VALUE OPPORTUNITY L-A | RVI GLOBAL VALOR | 10,058000 | 19/11/2026 | 16,52% | 53,72% | *** |
| OFI INVEST ISR ACTIONS JAPON RF H | RVI JAPÓN | 172,200000 | 18/11/2026 | 16,52% | 72,22% | ND |
| SCHRODER ISF FRONTIER MARKETS EQUITY C ACC GBP | RVI EMERGENTES | 432,017923 | 19/11/2026 | 16,52% | 74,64% | ** |
| SCHRODER ISF JAPANESE OPPORTUNITIES C ACC EUR (HEDGED) | RVI JAPÓN VALOR | 47,555100 | 19/11/2026 | 16,52% | 82,51% | *** |
| STEWART INVESTORS ASIA PACIFIC LEADERS VI GBP CAP | RVI ASIA EX-JAPÓN | 18,637489 | 19/11/2026 | 16,52% | 32,96% | ** |
| UBS (LUX) DIGITAL HEALTH EQUITY K-1-ACC | RVI SALUD | 770,240700 | 18/11/2026 | 16,52% | 32,50% | **** |
| BNP PARIBAS JAPAN EQUITY CLASSIC H EUR CAP | RVI JAPÓN | 244,550000 | 19/11/2026 | 16,51% | 85,21% | ***** |
| GOLDMAN SACHS JAPAN EQUITY PORTFOLIO R (SNAP) USD CAP | RVI JAPÓN | 14,101164 | 19/11/2026 | 16,51% | 50,15% | ** |
| INVESCO EMERGING MARKETS EQUITY C DIS ANNUAL GROSS EUR | RVI EMERGENTES | 21,030000 | 19/11/2026 | 16,51% | 61,64% | ** |
| JPM GLOBAL HEALTHCARE I (ACC) EUR | RVI SALUD | 191,020000 | 19/11/2026 | 16,51% | 32,87% | *** |